Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - YES.
作者信息
Kister Ilya
机构信息
NYU Multiple Sclerosis Comprehensive Care Center, Department of Neurology, NYU School of Medicine, New York, NY, USA.
出版信息
Mult Scler. 2017 Aug;23(9):1188-1190. doi: 10.1177/1352458517709957. Epub 2017 Jul 4.
PMID:28673111
Abstract
摘要
Zotero 插件